Consumer & Travel Stock News

Monday, October 12, 2026

Other News

Eli Lilly Reports Positive Taltz-Zepbound Combo Results for Psoriasis, Obesity Monster Beverage Price Target Cut From $95 to $52 Southwest Considers Boeing 787s for Long-Haul Expansion Novo Nordisk Loses Key Patent, Facing Ozempic and Wegovy Generics by 2031 Amazon Faces Possible Grid Cuts in Mississippi During Peak Demand Volkswagen Unveils Electric ID. Tiguan to Replace ID.4 and ID.5 Ryanair warns fares could stay high into 2028 amid Iran conflict Pyxis Oncology Sees GordonMD Raise Stake to Nearly 28 Million Shares Abivax Draws 12 Buy Ratings as Analysts See 84% Upside Carrefour Sells 35 Store Properties, Explores Codifrance Purchase Retension Prices $45 Million IPO; Blueprint Plans 229 Layoffs Harmony Biosciences Shares Fall on Profit-Taking After Pediatric WAKIX Approval EU and China Reach Initial Trade Deal on Autos Amazon Issues 100-Year Bonds as BNP Forecasts 43%-45% AWS Revenue Growth STEX Receives Nasdaq Notice for Falling Below Minimum Bid Price Requirement Roche Wins FDA Nod for Tecentriq in Stage III dMMR Colon Cancer Live Nation Announces Pricing of $730M and €600M Senior Notes Due 2032 MBRX Shareholders Approve Potential Reverse Stock Split and Increased Equity Plan Shares Boot Barn Hits 52-Week Low as Same-Store Sales Slow JPMorgan Bets Big on Definium's Brain Drug — But Can a Small Biotech Really Double From Here? HCW Biologics Gets FDA Roadmap for Cancer Drug — But Can a $25 Million Company Survive the Journey to the Clinic? Euro Hits 17-Month Low on French Debt Concerns